Literature DB >> 32002924

Gene-Environment Interactions and Role of Epigenetics in Anxiety Disorders.

Eugene Lin1,2,3, Shih-Jen Tsai4,5,6.   

Abstract

Several environmental risk factors such as early adverse childhood experiences, stress, and stressful life events are associated with anxiety disorders. Current approaches such as epigenetics and gene-environment interactions were used to identify candidate biomarkers for anxiety disorders to assess determinants of disease. In this chapter, in relation to gene-environment interactions, a variety of association studies regarding anxiety disorders were surveyed. We then showed supporting results from recent association studies such as human studies and animal models in terms of the epigenetic contribution to disease susceptibility to anxiety disorders. At last, future directions and limitations are highlighted. With the advances in multi-omics technologies, innovative ideas regarding disease prevention and drug responsiveness in anxiety disorders require further research in epigenetics and gene-environment interactions.

Entities:  

Keywords:  Anxiety disorders; Biomarkers; Epigenetics; Gene-environment interactions; Stress

Mesh:

Year:  2020        PMID: 32002924     DOI: 10.1007/978-981-32-9705-0_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Long-term antibiotic use during early life and risks to mental traits: an observational study and gene-environment-wide interaction study in UK Biobank cohort.

Authors:  Xiao Liang; Jing Ye; Yan Wen; Ping Li; Bolun Cheng; Shiqiang Cheng; Li Liu; Lu Zhang; Mei Ma; Xin Qi; Chujun Liang; Xiaomeng Chu; Om Prakash Kafle; Yumeng Jia; Feng Zhang
Journal:  Neuropsychopharmacology       Date:  2020-08-16       Impact factor: 7.853

Review 2.  Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders.

Authors:  Eunsoo Won; Yong-Ku Kim
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

3.  Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study.

Authors:  Christina van der Feltz-Cornelis; Sally Brabyn; Jonathan Ratcliff; Danielle Varley; Victoria Allgar; Simon Gilbody; Chris Clarke; Dimitris Lagos
Journal:  Brain Behav Immun Health       Date:  2021-02-24

4.  Editorial: Neuroepigenetics of Neuropsychiatric Disease-Hope, Success and Obstacles for Translational Findings and Applications.

Authors:  Yan Jiang; Julia M Schulze-Hentrich; Mira Jakovcevski
Journal:  Front Neurosci       Date:  2022-04-01       Impact factor: 5.152

5.  Effects of stressful life-events on DNA methylation in panic disorder and major depressive disorder.

Authors:  Darina Czamara; Alexa Neufang; Roman Dieterle; Stella Iurato; Janine Arloth; Jade Martins; Marcus Ising; Elisabeth E Binder; Angelika Erhardt
Journal:  Clin Epigenetics       Date:  2022-04-27       Impact factor: 7.259

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.